Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: ELABELA ameliorates hypoxic/ischemic-induced bone mesenchymal stem cell apoptosis via alleviation of mitochondrial dysfunction and activation of PI3K/AKT and ERK1/2 pathways

Fig. 2

ELA promoted MSC proliferation (a) and viability (b) under H/I exposure. Cell viability = (OD value in each group − OD value of CCK8 and medium/OD value in control group − OD value of CCK8 and medium) × 100%. All experiments were performed in triplicate. *P < 0.05. ELA, ELABELA; MSC, mesenchymal stem cell; H/I, hypoxic/ischemic; CCK8, cell counting kit-8

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512